mTOR
MTOR (mechanistic target of rapamycin) is a serine/threonine kinase that regulates cellular metabolism, growth ad survival. It mediates the cellular response to stress, growth factor and hormone etc. It is involved in cancer, aging and neurodegenerative diseases etc.
Products for mTOR
- Cat.No. 产品名称 Information
- GC34909 JR-AB2-011 JR-AB2-011 is a potent inhibitor of mTOR-mLST8-mSIN1-Rictor complex (mTORC2) which can block mTORC2 signaling and Rictor association with mTOR at lower effective concentrations.
- GC34121 CC-115 hydrochloride A dual inhibitor of mTOR and DNA-PK
- GC33385 PQR-530 A dual inhibitor of PI3Kα and mTOR
- GC33355 FT-1518 FT-1518是一种选择性的,可口服的,有效的新一代mTORC1和mTORC2抑制剂,具有抗肿瘤的活性。
-
GC33115
Pomiferin (NSC 5113)
橙桑黄酮; NSC 5113
Pomiferin (NSC 5113) (NSC 5113) 作为 HDAC 的潜在抑制剂,其 IC50 为 1.05 μM,并且还有效抑制 mTOR (IC50, 6.2 μM)。
- GC33014 NSC781406 A dual inhibitor of PI3K and mTOR
- GC32891 PQR620 PQR620 is a novel, selective, orally bioavailable and brain penetrant dual TORC1/2 inhibitor. PQR620 has anti-tumor activity across 56 lymphoma models with a median IC50 of 250 nM after 72 h of exposure.
-
GC32767
3BDO
3BDO,MTOR激酶激活剂,自噬抑制剂
A butyrolactone derivative and autophagy inhibitor - GC30229 Cbz-B3A Cbz-B3A是mTORC1转导的有效选择性抑制剂,与泛素1、2、4结合,Cbz-B3A还能抑制eIF4E结合蛋白的磷酸化。
-
GC19300
PQR309
PQR309
PQR309 是一种有效的脑渗透性口服生物利用度泛 I 类 PI3K/mTOR 抑制剂,对 PI3Kα、PI3Kδ、PI3Kβ、PI3Kγ 和 mTOR 的 IC50 分别为 33nM、451nM、661nM、708nM 和 89nM .PQR309 在人脑胶质瘤细胞中通过抑制增殖、诱导细胞凋亡、诱导 G1 细胞周期停滞、抑制侵袭和迁移等方式发挥抗肿瘤作用。 - GC19283 PF-04979064 PF-04979064 是一种有效的选择性 PI3K/mTOR 双激酶抑制剂,对 PI3Kα 和 mTOR 的 Kis 分别为 0.13 nM 和 1.42 nM。
- GC19114 CZ415 An mTOR inhibitor
-
GC18583
D-α-Hydroxyglutaric Acid
R-2-羟基戊二酸,(R)-2-Hydroxyglutarate; (R)-2-Hydroxyglutaric acid; (R)-2-Hydroxypentanedioic acid
An α-hydroxy acid
- GC11607 Rapalink-1 第三代二价 mTOR 抑制剂 RapaLink-1 通过惰性化学接头将雷帕霉素与 MLN0128 结合。 RapaLink-1 显示出比雷帕霉素或 mTOR 激酶抑制剂 (TORKi) 更好的功效,可有效阻断癌症衍生的激活 mTOR 突变体。 RapaLink-1 可以穿过血脑屏障。 RapaLink-1 与 FKBP12 的结合导致 mTORC1 的靶向和持久抑制。 RapaLink-1 通过改善自噬在抗磷脂综合征中发挥抗血栓作用。抗癌活性。
- GC10228 GDC-0084 PI3K and mTOR inhibitor, brain-permeable
- GC15740 OXA-01 A selective dual inhibitor of mTORC1 and mTORC2
-
GC13648
CC-223
CC-223; ATG-008
A potent, selective inhibitor of mTOR - GC16654 CC-115 A dual inhibitor of mTOR and DNA-PK
-
GC14371
LY3023414
LY3023414
LY3023414 (LY3023414) potently and selectively inhibits class I PI3K isoforms, DNA-PK, and mTORC1/2 with IC50s of 6.07 nM, 77.6 nM, 38 nM, 23.8 nM, 4.24 nM and 165 nM for PI3Kα, PI3Kβ, PI3Kδ , PI3Kγ, DNA-PK 和 mTOR, 分别。 LY3023414 在低纳摩尔浓度下有效抑制 mTORC1/2。 - GC13790 MHY1485 MHY1485 是一种有效的 mTOR 激活剂,可抑制自噬以及自噬体与溶酶体之间的融合。
- GC17338 GNE-317 A dual PI3Kα and mTOR inhibitor
- GC10340 GNE-477 A dual PI3K and mTOR inhibitor
- GC15423 GNE-493 A dual inhibitor of PI3K and mTOR
-
GC17330
(+)-Usniacin
(+)-地衣酸
(+)-Usniacin 从地衣中分离出来,结合在 mTOR 的 ATP 结合口袋,并抑制 mTORC1/2 活性。 (+)-Usniacin 抑制 mTOR 下游效应子的磷酸化:Akt (Ser473)、4EBP1、S6K,诱导自噬,具有抗癌活性。 (+)-Usniacin 对许多浮游革兰氏阳性菌具有抗菌活性,包括金黄色葡萄球菌、粪肠球菌和粪肠球菌。 -
GC10583
WAY-600
6-(1H-吲哚-5-基)-4-(4-吗啉基)-1-[1-(3-吡啶基甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶
An mTOR inhibitor -
GC13071
Ridaforolimus (Deforolimus, MK-8669)
42-(二甲基亚膦酰)雷帕霉素,MK-8669; Deforolimus; AP23573
A rapamycin analog that selectively inhibits mTOR in mTORC1 -
GC13321
WYE-687
N-[4-[4-(4-吗啉基)-1-[1-(3-吡啶甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]氨基甲酸甲酯
An mTOR inhibitor -
GC11177
GDC-0980 (RG7422)
(S)-1-[4-[[2-(2-氨基嘧啶-5-基)-7-甲基-4-(吗啉-4-基)噻吩并[3,2-D]嘧啶-6-基]甲基]哌嗪-1-基]-2-羟基丙-1-酮,GDC-0980; GNE 390; RG 7422
A dual inhibitor of PI3K and mTOR -
GC13858
Torin 2
9-(6-氨基-3-吡啶基)-1-[3-(三氟甲基)苯基]苯并[H]-1,6-萘啶-2(1H)-酮
Selective inhibitor of mTOR -
GC11018
GSK1059615
(5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮
A potent PI3K inhibitor -
GC15653
PF-05212384 (PKI-587)
N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N'-[4-[4,6-二(4-吗啉基)-1,3,5-三嗪-2-基]苯基]脲,PKI-587; PF-05212384
A potent, dual PI3K/mTOR inhibitor -
GC14071
OSI-027
反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]环己烷羧酸,ASP7486
Dual mTORC1/mTORC2 inhibitor - GC11003 PP121 A potent dual inhibitor of tyrosine and phosphoinositide kinases
-
GC14675
WYE-125132 (WYE-132)
N-[4-[1-(1,4-二氧杂螺[4.5]癸烷-8-基)-4-(8-氧杂-3-氮杂双环[3.2.1]辛烷-3-基)-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]-N'-甲基脲,WYE-125132
Dual mTORC1/mTORC2 inhibitor -
GC10196
ETP-46464
ATM Inhibitor III, ATR Inhibitor III
An ATR inhibitor -
GC12773
Palomid 529
P529
An inhibitor of mTORC1 and mTORC2 formation -
GC15072
GSK2126458
GSK212; GSK-2126458; GSK 2126458; GSK-212; GSK 212
A potent pan-PI3K and mTOR inhibitor -
GC10969
INK 128 (MLN0128)
沙帕色替; INK-128; MLN0128; TAK-228
Inhibitor of TORC1/2 - GC17104 PKI-402 A dual inhibitor of PI3K and mTOR
-
GC16417
PF-04691502
2-氨基-8-[反式-4-(2-羟基乙氧基)环己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮
PF-04691502 是一种有效的选择性 PI3K 和 mTOR 抑制剂。 PF-04691502 与人 PI3Kα、β、δ、γ 和 mTOR 结合,Kis 分别为 1.8、2.1、1.6、1.9 和 16 nM。 -
GC16145
NVP-BGT226
NVP-BGT226 maleate
A dual PI3K and mTOR inhibitor -
GC13029
AZD2014
3-[2,4-双((3S)-3-甲基吗啉-4-基)吡啶并[5,6-E]嘧啶-7-基]-N-甲基苯甲酰胺,AZD 2014; AZD-2014
A potent dual mTORC1/2 inhibitor -
GC15904
PP242
PP242; PP-242
Potent inhibitor of mTOR kinase in both mTORC1 and mTORC2 -
GC12573
Temsirolimus
西罗莫司脂化物,Torisel;CCI-779;CCI 779;CCI779
A specific inhibitor of mTOR activity -
GC10131
Torin 1
1-[4-[4-(1-氧代丙基)-1-哌嗪基]-3-(三氟甲基)苯基]-9-(3-喹啉基)苯并[H]-1,6-萘啶-2(1H)-酮,Torin1;Torin-1
Selective inhibitor of mTOR
-
GC12021
GDC-0349
N-ETHYL-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-D]嘧啶-2-基]苯基]脲
A potent inhibitor of mTOR - GC14346 KU-0060648 A dual inhibitor of DNA-PK and PI3K
-
GC16380
AZD8055
CCG-168
AZD8055是一种新型的ATP竞争性mTOR抑制剂,IC50 为0.8 nmol/L,Ki为1.3 nmol/L。 -
GC10662
WYE-354
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯
Potent inhibitor of mTOR in both mTORC1 and mTORC2 - GC15167 KU-0063794 An inhibitor of mTORC1 and mTORC2